Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497).

Molyneux E, Merrick B, Khanim FL, Banda K, Dunn JA, Iqbal G, Bunce CM, Drayson MT.

Br J Haematol. 2014 Mar;164(6):888-90. doi: 10.1111/bjh.12681. Epub 2013 Nov 25. No abstract available.

PMID:
24266453
2.

Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi.

Israëls T, van de Wetering MD, Hesseling P, van Geloven N, Caron HN, Molyneux EM.

Pediatr Blood Cancer. 2009 Jul;53(1):47-52. doi: 10.1002/pbc.22032.

PMID:
19338050
3.

[Maxillofacial location of Burkitt lymphoma at the University Hospital Center of Ouagadougou, Burkina Faso].

Ouoba K, Dao M, Sakande B, Kabre M, Cisse R, Sanou A.

Med Trop (Mars). 1997;57(4):415-6. French. No abstract available.

PMID:
9612790
4.

Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML).

Murray JA, Khanim FL, Hayden RE, Craddock CF, Holyoake TL, Jackson N, Lumley M, Bunce CM, Drayson MT.

Br J Haematol. 2010 Apr;149(1):65-9. doi: 10.1111/j.1365-2141.2009.08055.x. Epub 2010 Jan 13.

PMID:
20067564
5.

The 2000 Burkitt lymphoma trial in Malawi.

Hesseling P, Broadhead R, Mansvelt E, Louw M, Wessels G, Borgstein E, Schneider J, Molyneux E.

Pediatr Blood Cancer. 2005 Mar;44(3):245-50.

PMID:
15547922
6.

Rituximab in a child with relapsed Burkitt lymphoma.

Bay A, Dogan M, Acikgoz M, Oner AF.

Pediatr Blood Cancer. 2007 Aug;49(2):218. No abstract available.

PMID:
16847929
7.

Rescue chemotherapy for patients with resistant or relapsed endemic Burkitt's lymphoma.

Hesseling PB, Molyneux E, Kamiza S, Broadhead R.

Trans R Soc Trop Med Hyg. 2008 Jun;102(6):602-7. doi: 10.1016/j.trstmh.2008.02.009. Epub 2008 Apr 15.

PMID:
18417177
8.

Malawi pilot study of Burkitt lymphoma treatment.

Hesseling PB, Broadhead R, Molyneux E, Borgstein E, Schneider JW, Louw M, Mansvelt EP, Wessels G.

Med Pediatr Oncol. 2003 Dec;41(6):532-40.

PMID:
14595710
9.

[Therapeutic results in Burkitt's lymphoma].

López J, Melero C, Montalbán MA, García-Muñoz F, Nazario G, Valverde F, Gil C, Bernacer M, Aracil J, Contra T, et al.

An Esp Pediatr. 1988 Oct;29 Suppl 34:141-4. Spanish. No abstract available.

PMID:
3214024
10.

Treating Burkitt's lymphoma in Malawi, Cameroon, and Ghana.

Hesseling PB, Molyneux E, Tchintseme F, Welbeck J, McCormick P, Pritchard-Jones K, Wagner HP.

Lancet Oncol. 2008 Jun;9(6):512-3. doi: 10.1016/S1470-2045(08)70139-6. No abstract available.

PMID:
18510986
11.

Endemic Burkitt lymphoma of maxillofacial region: results of induction treatment with cyclophosphamide plus methotrexate in West Africa.

Béogo R, Nacro B, Ouédraogo D, Ouoba K.

Pediatr Blood Cancer. 2011 Jul 1;56(7):1068-70. doi: 10.1002/pbc.23058. Epub 2011 Feb 22.

PMID:
21344617
12.

[Non-Hodgkin lymphomas of the Burkitt type].

Herrero Díez A, Lamamie de Clairac P, Muro Brussi M, Meana Meana A, Donoro Mazario M.

An Esp Pediatr. 1988 Oct;29 Suppl 34:112-3. Spanish. No abstract available.

PMID:
3214015
13.

The use of anthracyclines in the treatment of endemic Burkitt lymphoma.

Molyneux E, Schwalbe E, Chagaluka G, Banda K, Israels T, Depani S, Mittermayer-Vassallo K, Windebank K, Mvula J, Njiram'madzi J, O'Brien S, Carey P, Bailey S.

Br J Haematol. 2017 Jun;177(6):984-990. doi: 10.1111/bjh.14440. Epub 2016 Nov 28.

PMID:
27891583
14.

Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia.

Griskevicius L, Stulpinas R, Vengalyte I, Saulyte-Trakymiene S, Mickys U, Pranys D, Kurtinaitis J, Jurgutis M.

Leuk Res. 2009 Apr;33(4):587-8. doi: 10.1016/j.leukres.2008.07.024. Epub 2008 Aug 31. No abstract available.

PMID:
18762337
15.

Burkitt lymphoma in children: the Israeli experience.

Eldar AH, Futerman B, Abrahami G, Attias D, Barak AB, Burstein Y, Dvir R, Gabriel H, Horovitz J, Kapelushnik J, Kaplinsky H, Miskin H, Sthoeger D, Toren A, Vilk-Revel S, Weintraub M, Yaniv I, Linn S, Arush MB.

J Pediatr Hematol Oncol. 2009 Jun;31(6):428-36. doi: 10.1097/MPH.0b013e31819a5d58.

PMID:
19648792
16.

Refractoriness to rituximab monotherapy in a child with relapsed/refractory Burkitt non-Hodgkin lymphoma.

Okur FV, Oguz A, Karadeniz C, Citak C, Poyraz A, Boyunaga O.

Pediatr Hematol Oncol. 2006 Jan-Feb;23(1):25-31.

PMID:
16326409
17.

Kenya and Uganda grapple with Burkitt lymphoma.

Wakabi W.

Lancet Oncol. 2008 Apr;9(4):319. No abstract available.

PMID:
18380064
18.

Burkitt lymphoma involving the clivus.

Aronson PL, Reilly A, Paessler M, Kersun LS.

J Pediatr Hematol Oncol. 2008 Apr;30(4):320-1. doi: 10.1097/MPH.0b013e318162bd1c.

PMID:
18391704
19.

Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.

Todeschini G, Bonifacio M, Tecchio C, Balter R, Carli G, Stefani PM, Adami F, Zamò A, Dei Tos AP, Marino F, Gherlinzoni F, Marradi P, Semenzato G, Pizzolo G.

Am J Hematol. 2012 Jan;87(1):22-5. doi: 10.1002/ajh.22189. Epub 2011 Nov 16.

20.

[Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].

Meng JH, Gao YJ, Lu FJ, Zhai XW, Wang HS, Li J.

Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):222-7. doi: 10.3760/cma.j.issn.0253-3766.2012.03.014. Chinese.

PMID:
22780979

Supplemental Content

Support Center